14:48:19 EST Fri 15 Dec 2017
Enter Symbol
or Name
USA
CA



Q:AMBS - AMARANTUS BIOSCIENCE HOLDINGS IN - http://www.amarantus.com14:48:19 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AMBS - Qnot subscribed0.1237+0.045758.64,679.25164790.076  0.134  0.0760.09  0.0114:27:48Dec 1415 min RT 2¢

Recent Trades - Last 10 of 479
Time ETExPriceChangeVolume
14:27:48Q0.12370.0457300
14:27:47Q0.1240.046300
14:27:45Q0.1240.0468,000
14:27:38Q0.1240.0465,000
14:25:32Q0.1250.04710,000
14:24:48Q0.1250.047100
14:24:12Q0.1230.0452,800
14:21:37Q0.12410.04614,017
14:19:23Q0.1220.04415,000
14:19:17Q0.1240.04630,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2017-12-14 08:00U:AMBSNews ReleaseAmarantus Subsidiary MANF Therapeutics Announces Publication in Science Magazine of Positive Animal Data for MANF in Treatment of Retinal Damage and Issuance of Retinal Patent in Japan Covering MANF and CDNF
2017-12-11 08:00U:AMBSNews ReleaseAmarantus Subsidiary MANF Therapeutics Receives Notice of Allowance from U.S. Patent & Trademark Office Covering MANF Treatment of Diabetes
2017-12-08 10:28U:AMBSNews ReleaseAmarantus Subsidiary Elto Pharma Announces the Issuance of Patents in Singapore and New Zealand Covering Treatment of Parkinson ’s LID
2017-12-05 07:45U:AMBSNews ReleaseAmarantus Subsidiary Elto Pharma Receives Notice of Allowance for European Patent Application Covering Method of Treating Cognitive Impairment Associated with Alzheimer's Disease and Parkinson's disease with Eltoprazine
2017-12-01 10:06U:AMBSNews ReleaseAmarantus Provides Comprehensive Corporate Update